Nov 21 (Reuters) - SDI Ltd (SDI) :
- SDI RECEIVES US FDA APPROVAL FOR NEW AMALGAM REPLACEMENT PRODUCT
- REGULATORY APPROVAL RECEIVED FROM U.S. FDA FOR SDI'S AMALGAM REPLACEMENT PRODUCT 'STELA'
- FORMAL LAUNCH OF PRODUCT IN US ANTICIPATED IN Q1FY24
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
87.0¢ |
Change
0.015(1.75%) |
Mkt cap ! $103.4M | |||
| Open | High | Low | Value | Volume |
| 86.0¢ | 87.0¢ | 86.0¢ | $16.58K | 19.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23946 | 86.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 87.0¢ | 28849 | 1 |
View Market Depth
| Last trade - 16.10pm 28/07/2025 (20 minute delay) ? |
| SDI (ASX) Chart |